vs
Innoviva, Inc.（INVA）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是Innoviva, Inc.的1.6倍（$188.3M vs $114.6M），Innoviva, Inc.净利率更高（143.2% vs 47.9%，领先95.3%），Innoviva, Inc.同比增速更快（24.8% vs -21.9%），过去两年Innoviva, Inc.的营收复合增速更高（21.6% vs -15.4%）
Innoviva Inc是一家专注于呼吸道疾病、传染病及重症护理领域处方治疗药物研发、商业化及特许权使用费管理的医疗保健企业，与全球领先制药商合作，为北美、欧洲等核心市场的患者提供哮喘、慢性阻塞性肺疾病等病症的治疗方案。
INVA vs RILY — 直观对比
营收规模更大
RILY
是对方的1.6倍
$114.6M
营收增速更快
INVA
高出46.7%
-21.9%
净利率更高
INVA
高出95.3%
47.9%
两年增速更快
INVA
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.6M | $188.3M |
| 净利润 | $164.2M | $90.3M |
| 毛利率 | 66.0% | 79.5% |
| 营业利润率 | 34.0% | 32.3% |
| 净利率 | 143.2% | 47.9% |
| 营收同比 | 24.8% | -21.9% |
| 净利润同比 | 707.4% | 1710.8% |
| 每股收益（稀释后） | $2.19 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVARILY
| Q4 25 | $114.6M | $188.3M | ||
| Q3 25 | $107.8M | $215.3M | ||
| Q2 25 | $100.3M | $188.2M | ||
| Q1 25 | $88.6M | $197.2M | ||
| Q4 24 | $91.8M | $241.0M | ||
| Q3 24 | $89.5M | $225.5M | ||
| Q2 24 | $99.9M | $256.0M | ||
| Q1 24 | $77.5M | $263.4M |
净利润INVARILY
| Q4 25 | $164.2M | $90.3M | ||
| Q3 25 | $89.9M | $91.1M | ||
| Q2 25 | $63.7M | $139.5M | ||
| Q1 25 | $-46.6M | $-10.0M | ||
| Q4 24 | $20.3M | $-5.6M | ||
| Q3 24 | $1.2M | $-284.4M | ||
| Q2 24 | $-34.7M | $-433.6M | ||
| Q1 24 | $36.5M | $-49.2M |
毛利率INVARILY
| Q4 25 | 66.0% | 79.5% | ||
| Q3 25 | 70.1% | 83.7% | ||
| Q2 25 | 82.9% | 81.3% | ||
| Q1 25 | 82.7% | 81.4% | ||
| Q4 24 | 85.1% | 79.8% | ||
| Q3 24 | 81.6% | 82.1% | ||
| Q2 24 | 85.1% | 84.5% | ||
| Q1 24 | 77.5% | 85.3% |
营业利润率INVARILY
| Q4 25 | 34.0% | 32.3% | ||
| Q3 25 | 32.1% | 30.4% | ||
| Q2 25 | 48.6% | 5.7% | ||
| Q1 25 | 46.7% | -31.2% | ||
| Q4 24 | 47.0% | -69.2% | ||
| Q3 24 | 48.3% | -36.4% | ||
| Q2 24 | 54.7% | -90.8% | ||
| Q1 24 | 33.3% | -6.1% |
净利率INVARILY
| Q4 25 | 143.2% | 47.9% | ||
| Q3 25 | 83.4% | 42.3% | ||
| Q2 25 | 63.5% | 74.1% | ||
| Q1 25 | -52.6% | -5.1% | ||
| Q4 24 | 22.1% | -2.3% | ||
| Q3 24 | 1.4% | -126.1% | ||
| Q2 24 | -34.7% | -169.4% | ||
| Q1 24 | 47.1% | -18.7% |
每股收益（稀释后）INVARILY
| Q4 25 | $2.19 | $2.78 | ||
| Q3 25 | $1.08 | $2.91 | ||
| Q2 25 | $0.77 | $4.50 | ||
| Q1 25 | $-0.74 | $-0.39 | ||
| Q4 24 | $0.43 | $-0.01 | ||
| Q3 24 | $0.02 | $-9.39 | ||
| Q2 24 | $-0.55 | $-14.35 | ||
| Q1 24 | $0.46 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $550.9M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $1.2B | $-171.5M |
| 总资产 | $1.6B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INVARILY
| Q4 25 | $550.9M | $226.6M | ||
| Q3 25 | $476.5M | $184.2M | ||
| Q2 25 | $397.5M | $267.4M | ||
| Q1 25 | $319.1M | $138.3M | ||
| Q4 24 | $305.0M | $146.9M | ||
| Q3 24 | $260.6M | $159.2M | ||
| Q2 24 | $217.0M | $236.9M | ||
| Q1 24 | $178.4M | $190.7M |
总债务INVARILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益INVARILY
| Q4 25 | $1.2B | $-171.5M | ||
| Q3 25 | $1.0B | $-260.5M | ||
| Q2 25 | $714.8M | $-351.7M | ||
| Q1 25 | $646.9M | $-496.8M | ||
| Q4 24 | $691.2M | $-488.2M | ||
| Q3 24 | $668.5M | $-497.6M | ||
| Q2 24 | $665.5M | $-218.3M | ||
| Q1 24 | $703.7M | $228.4M |
总资产INVARILY
| Q4 25 | $1.6B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.8B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $1.2B | $3.2B | ||
| Q1 24 | $1.3B | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.5M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.33× | 0.29× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流INVARILY
| Q4 25 | $54.5M | $26.2M | ||
| Q3 25 | $49.7M | $-60.6M | ||
| Q2 25 | $44.1M | $-25.6M | ||
| Q1 25 | $48.6M | $184.0K | ||
| Q4 24 | $59.2M | $-2.7M | ||
| Q3 24 | $48.7M | $19.5M | ||
| Q2 24 | $43.7M | $111.5M | ||
| Q1 24 | $37.0M | $135.4M |
自由现金流INVARILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $48.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率INVARILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度INVARILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率INVARILY
| Q4 25 | 0.33× | 0.29× | ||
| Q3 25 | 0.55× | -0.66× | ||
| Q2 25 | 0.69× | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.91× | — | ||
| Q3 24 | 40.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INVA
| Royalty | $54.9M | 48% |
| Xacduro | $32.1M | 28% |
| Giapreza | $19.6M | 17% |
| Xerava | $7.3M | 6% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
